Conference Coverage

Revascularization in paraplegics best performed with PCI


 

AT THE 2018 CRT MEETING


As a result, he initiated his own study, looking for such cases in the New York State Inpatient Database, in which there were 1,400 patients with paraplegia or quadriplegia and more than 400,000 without these limb impairments who had presented with acute MI over the period of study. After comparing outcomes in these two groups, a subsequent analysis was performed in which each patient with paraplegia/quadriplegia was matched by propensity scoring to five patients from the database without paraplegia/quadriplegia.

Notably, patients with paraplegia/quadriplegia were found to represent a small but steady proportion of acute MI cases. With only modest variation, the rate hovered around 0.2%-0.3% of cases per year.

“The patients with paraplegia or quadriplegia tended to be somewhat younger [67 vs. 70 years of age; P less than .001], have more comorbidities, and were more likely to be enrolled in Medicare,” Dr. Dai reported.

Of patients in the database without paraplegia/quadriplegia, 56% received medical therapy alone and 14% underwent catheterization but were not revascularized. Of the 31% who were revascularized, 82% underwent PCI, and the remainder underwent CABG.

Among those with paraplegia/quadriplegia, 83.7% were managed medically and 7.2% underwent catheterization but no revascularization. Of the 9.1% who were revascularized, 7.2% underwent PCI and 1.9% underwent CABG.

Recommended Reading

VIDEO: No short-term link found between PPIs, myocardial infarction
MDedge Cardiology
Overweight and obese individuals face greater cardiovascular morbidity
MDedge Cardiology
Abruptio placenta brings increased cardiovascular risk – and soon
MDedge Cardiology
Sex-triggered sudden cardiac arrest extremely rare
MDedge Cardiology
200 cardiovascular drugs now in development
MDedge Cardiology
Young diabetics are at sevenfold increased risk of sudden cardiac death
MDedge Cardiology
ACC Late-Breaking Clinical Trial sessions preview for day 1
MDedge Cardiology
ACC Day 2: Late-Breaking Clinical Trial highlights
MDedge Cardiology
Heart attacks soar in young IBD patients
MDedge Cardiology
ACC Day 3: Finishing strong in Late-Breaking Clinical Trial Sessions
MDedge Cardiology